With shares of Amazon (NASDAQ:AMZN) trading around $403, is AMZN an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:
T = Trends for a Stock’s MovementAmazon serves its customers through its retail websites and focus on selection, price, and convenience. The company also manufactures and sells Kindle devices. Amazon offers programs that enable sellers to sell their products on the company�� websites, including the sellers��own branded websites, and fulfill orders through them. Amazon also provides platforms that allow authors, musicians, filmmakers, app developers, and others to publish and sell content. Online commerce has been on the rise because of the convenience, efficiency, and relatively low prices offered.
It was a lucrative holiday shopping season for Amazon.com, but the e-commerce giant still left some shoppers disgruntled after Santa Claus failed to show up on time. According to Bloomberg, despite Amazon�� promise that all of its ordered packages would be delivered by Christmas, some shoppers still suffered empty doorsteps on the eve of the big day, and now the largest online retailer is working to make it up to them.�For those affected by Amazon�� inability to deliver packages the time, the Seattle, Washington-based retailer offered customers $20 gift cards and refunds on shipping charges — along with a promise that it would never happen again. Amazon doesn�� take full responsibility for the shipping shortcomings, as it cites failures in the United Parcel Service�� (NYSE:UPS) transportation network in addition to its onslaught of last-minute orders, but the company issued gift cards to compensate customers nonetheless, and promised to look into UPS difficulties.
Top 10 Net Payout Yield Stocks For 2015: GTx Inc.(GTXI)
GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions. The company markets FARESTON (toremifene citrate) 60 mg tablets for the treatment of metastatic breast cancer in postmenopausal women primarily through wholesale drug distributors in the United States. It is developing selective androgen receptor modulators (SARMs), including Ostarine (GTx-024), which has completed Phase II clinical trial for the prevention and treatment of muscle wasting in patients with non-small cell lung cancer; and CapesarisTM (GTx-758), a selective estrogen receptor alpha agonist that has completed Phase IIa clinical trial for the first line treatment of advanced prostate cancer. In addition, the company is developing estrogen receptor beta agonists and other novel compounds that are in preclinical development stage for the treatment of metabo lic diseases, ophthalmic diseases, cancer, psoriasis, and/or pain. The company was founded in 1997 and is headquartered Memphis, Tennessee.
Advisors' Opinion:- [By Roberto Pedone]
One biopharmaceutical player that's rapidly moving within range of triggering a major breakout trade is GTx (GTXI), which is dedicated to the discovery, development and commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis and bone loss, muscle loss and other serious medical condition. This stock has been hammered by the bears so far in 2013, with shares off sharply by 53%.
If you look at the chart for GTx, you'll notice that this stock recently gapped down sharply from over $4 to below $1.50 a share with heavy downside volume. Following that gap down, shares of GTXI have rebounded sharply and started to uptrend, with the stock moving higher from its low of $1.31 to its recent high of $1.96 a share. During that move, shares of GTXI have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of GTXI within range of triggering a major breakout trade.
Traders should now look for long-biased trades in GTXI if it manages to break out above some near-term overhead resistance at $1.96 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 1.35 million shares. If that breakout triggers soon, then GTXI will set up to re-fill some of its previous gap down zone from August that started just above $4 a share. Some possible upside targets if GTXI gets into that gap with volume are $2.50 to $3 a share, or possibly even $3.50 a share.
Traders can look to buy GTXI off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support at $1.50 a share. One can also buy GTXI off strength once it takes out $1.96 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By James E. Brumley]
If you were lucky enough to step into Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) when your truly suggested it was a budding buy back on December 23rd, then congratulations - you're now up a little more than 60% (assuming you bought into RNN after the break above a key resistance line on the 27th). Now get out. Instead, use your profits from the Rexahn to take on a stake in GTx, Inc. (NASDAQ:GTXI). No, GTXI may not look like much at first, but when you take a step back and look at a chart of GTx, Inc. through a longer-term lens, the upside potential becomes clear.
Top 5 Low Price Companies To Invest In 2014: Solta Medical Inc(SLTM)
Solta Medical, Inc., together with its subsidiaries, engages in the design, development, manufacture, and marketing of energy-based medical device systems for aesthetic applications primarily in North America, the Asia Pacific, Europe, and the Middle East. It offers Fraxel re:pair system for use in dermatological procedures requiring ablation, coagulation, and resurfacing of soft tissue, as well as for rhytides, pigmentation, dyschromia, fine lines, acne, surgical scars, deeper lines, wrinkles, and actinic keratoses; and Clear + Brilliant system for patients who want to take control of their aging process. The company also provides Thermage CPT system that provides non-invasive treatment options for skin tightening; Liposonix system to destroy unwanted fat cells resulting in waist circumference reduction; Isolaz system for the treatment of inflammatory acne, comedonal acne, and mild to moderate inflammatory acne; and the CLARO device, a consumer handheld device for the tre atment of mild-to-moderate inflammatory acne, including pustular acne. Its customers principally include dermatologists, plastic surgeons, general and family practitioners, gynecologists, and ophthalmologists. The company sells its products primarily through a direct sales force, as well as through independent distributors; and CLARO device through retail and associated retailer?s Websites, and television retail networks, as well as through its own website in the United States. The company was formerly known as Thermage, Inc. and changed its name to Solta Medical, Inc. in January 2009. Solta Medical, Inc. was incorporated in 1996 and is headquartered in Hayward, California.
Advisors' Opinion:- [By Lauren Pollock]
Solta Medical Inc.(SLTM) unveiled restructuring plans to improve its financial performance and has hired an adviser to help evaluate strategic alternatives, including a possible sale or merger of the medical aesthetics device maker. Investors cheered the news, sending shares up 7.7% to $1.97 premarket.
Top 5 Low Price Companies To Invest In 2014: Jack In The Box Inc.(JACK)
Jack in the Box Inc. operates and franchises Jack in the Box quick-service restaurants and Qdoba Mexican Grill fast-casual restaurants. As of February 22, 2012, it operated and franchised 2,200 Jack in the Box restaurants in 20 states in the United States; and 600 Qdoba Mexican Grill restaurants in 42 states and the District of Columbia. The company was founded in 1951 and is based in San Diego, California.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Jack in the Box (Nasdaq: JACK ) , whose recent revenue and earnings are plotted below. - [By Ben Levisohn]
Shares of Ruby Tuesday have gained 4.8% to $7.59 this morning, making it the third-best performer in the S&P 1500 and outpacing other restaurant stocks. Jack in the Box (JACK) has dropped 0.8% to $38.76, DineEquity (DIN), which operates Applebee’s and IHOP, has gained 0.1%% to 66.12, Denny’s (DENN) has fallen 0.2% to $6.06 and recent-IPO Potbelly (PBPB) has gained 1.7% to $30.73.
Top 5 Low Price Companies To Invest In 2014: SK3 Group Inc (SKTO)
SK3 Group, Inc. (SK3), formerly CTT International Distributors Inc., is a development-stage company. The Company was formed by the merger of Slabsdirect.com, Inc. and CTT International Distributors Inc. SK3 has one subsidiary, CTT Distributors Ltd., which is the operating company. SK3 is in the e-commerce business and provides non-branded computer and electronic merchandise at discount prices to the Internet consumer through its Website www.cheaperthanthem.com. The Website is hosted by Ezyra E-Business Services, an unrelated party, which charges SK3 an annual fee to host the Website. In December 2009, Healthcare of Today, Inc. acquired controlling interest in the Company. In December 2009, the Company acquired NuvoDigital Technology, Inc., a data security technology firm based in Salt Lake City. In addition, in December 2009, the Company's parent company Healthcare of Today, Inc. acquired Xenotis Pty Ltd. In February 2011, the Company acquired PRN Registry. In March 2011, the Company completed the acquisition of HealthStaff Training Institute. In March 2011, the Company acquired W&M Medical Management, Inc. Effective March 14, 2013, the Company acquired Medical Greens, a provider of medical logistics services.
SK3 has a direct business, in which it buys and takes possession of excess electronic and computer inventory for resale (Direct Business). In addition, SK3 has a fulfillment partner business, in which SK3 facilitates the sale of merchandise of other retailers, cataloguers or manufacturers (Fulfillment Associates) through the Website (Fulfillment Business). For both the direct business and fulfillment business, SK3 has developed a consumer and a wholesaler sales channel.
SK3�� Direct Business involves buying and taking possession of inventory for resale. The Company offers moving picture experts group layer-3 audio (MP3) players and a frequency modulation (FM) transmitter accessory for MP3 players on the Website. SK3 seeks to become an online retailer offering non-b! randed electronic and computer merchandise for sale over the Internet. SK3�� Fulfillment Business sells merchandise of Fulfillment Associates through the Website. SK3 manages the orders collected for the Fulfillment Associates through the Website and forwards the orders on to the Fulfillment Associate, who then fills the order. The Fulfillment Associates perform essentially the same operations as a warehouse: order picking and shipping.
Advisors' Opinion:- [By James E. Brumley]
Truth be told, it's not clear if SK3 Group Inc. (OTCMKTS:SKTO) is best described when compared to a name like Cerner Corporation (NASDAQ:CERN), or to a Gentiva Health Services, Inc. (NASDAQ:GTIV). The company's got elements of both major industries being represented by CERN and GTIV (home health care, and information technology), with the addition of another budding industry thrown into the mix. One thing IS clear though... SKTO shares have decidedly reversed a nasty downtrend, and may now be one of the market's best small cap healthcare speculative trades.
No comments:
Post a Comment